BCD to Measure the ED95 of Remimazolam-Assisted Sedation in Arteriovenous Fistula Creation Surgery | MicrobiomeTrials← Back to trialsNCT06998732
BCD to Measure the ED95 of Remimazolam-Assisted Sedation in Arteriovenous Fistula Creation Surgery
CompletedNAINTERVENTIONAL
Trial Details
Start: 2025-06-01Est. Completion: 2026-09-30
Enrollment target: 50 participants Locations- Sir run run shaw hospital, Hangzhou, Zhejiang, China
Other microbiome trials you might be interested in
CABGGraft FailureColchicine
This is a single-center, prospective, randomized, open-label, assessor-blinded, blank-controlled exploratory (pilot) tri…
Shanghai, ChinaEst. completion Oct 2027
End Stage Renal Disease
VasQ is an external support implant for arteriovenous fistulas created for dialysis access.
This is a postmarket survei…
Long Beach, United StatesEst. completion Aug 2027
Recruiting
Metabolic DisordersCancerChronic Kidney DiseaseDiabetesNormal Physiology
Background:
Scientists have long used simple measures (such as height and weight) to estimate how much a person s body …
Bethesda, United StatesEst. completion Jul 1, 2031